Nantahala Capital Management
Latest statistics and disclosures from Nantahala Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, EW, HGV, HLF, SLNO, and represent 38.38% of Nantahala Capital Management's stock portfolio.
- Added to shares of these 10 stocks: IWM (+$41M), SLNO (+$40M), GOGO (+$32M), PTON (+$26M), FOXF (+$25M), HGV (+$18M), TNGX (+$16M), CHYM (+$15M), TBBK (+$15M), HLF (+$12M).
- Started 19 new stock positions in GOGO, NUVB.WS, LXEO, PHGE, BCRX, ARVN, CHYM, PCVX, GDEN, USNA. PEPG, ASRT, ITGR, KRRO, KZR, VYNE, Mara Holdings, GLUE, IMUX.
- Reduced shares in these 10 stocks: ESTA (-$72M), ABVX (-$55M), COGT (-$45M), XBI (-$37M), KRYS (-$35M), AMRX (-$22M), IMAX (-$19M), KROS (-$18M), CZR (-$16M), PVLA (-$16M).
- Sold out of its positions in AGIO, ANIK, AQST, Assertio Holdings, Biomx, CZR, CYTK, DCTH, DYN, ELDN. EVOK, KOD, KRYS, MAZE, PVLA, RDVT, HOOD, SCPH, GPCR, VTGN.
- Nantahala Capital Management was a net seller of stock by $-111M.
- Nantahala Capital Management has $3.0B in assets under management (AUM), dropping by 5.04%.
- Central Index Key (CIK): 0001472322
Tip: Access up to 7 years of quarterly data
Positions held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Nantahala Capital Management
Nantahala Capital Management holds 142 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf (IWM) | 22.9 | $694M | +6% | 2.8M | 246.16 |
|
| Edwards Lifesciences Put Option (EW) | 5.1 | $154M | 1.8M | 85.25 |
|
|
| Hilton Grand Vacations (HGV) | 3.9 | $118M | +17% | 2.6M | 44.75 |
|
| Herbalife Com Shs (HLF) | 3.7 | $112M | +12% | 8.7M | 12.89 |
|
| Soleno Therapeutics (SLNO) | 2.8 | $84M | +88% | 1.8M | 46.30 |
|
| Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA) | 2.6 | $78M | 2.5M | 31.21 |
|
|
| Peloton Interactive Cl A Com (PTON) | 2.5 | $77M | +51% | 12M | 6.16 |
|
| Ban (TBBK) | 2.4 | $72M | +25% | 1.1M | 67.52 |
|
| Establishment Labs Holdings Ord (ESTA) | 2.4 | $72M | -49% | 988k | 72.88 |
|
| Viatris Call Option (VTRS) | 2.1 | $62M | 5.0M | 12.45 |
|
|
| Xtant Med Hldgs Com New (XTNT) | 1.8 | $54M | 68M | 0.78 |
|
|
| Spdr Series Trust State Street Spd Put Option (XBI) | 1.6 | $49M | -42% | 400k | 121.93 |
|
| Fulcrum Therapeutics (FULC) | 1.6 | $49M | -8% | 4.3M | 11.31 |
|
| Bioventus Com Cl A (BVS) | 1.5 | $45M | +4% | 6.0M | 7.44 |
|
| Savara (SVRA) | 1.5 | $44M | -16% | 7.3M | 6.03 |
|
| Evolus (EOLS) | 1.3 | $39M | 5.8M | 6.65 |
|
|
| Fox Factory Hldg (FOXF) | 1.2 | $37M | +200% | 2.2M | 17.11 |
|
| Gogo (GOGO) | 1.0 | $32M | NEW | 6.8M | 4.66 |
|
| Tango Therapeutics (TNGX) | 1.0 | $32M | +97% | 3.6M | 8.86 |
|
| Regeneron Pharmaceuticals Call Option (REGN) | 1.0 | $31M | 40k | 771.87 |
|
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.0 | $31M | -42% | 2.4M | 12.60 |
|
| Eventbrite Com Cl A (EB) | 1.0 | $31M | 6.9M | 4.45 |
|
|
| Camping World Hldgs Cl A (CWH) | 1.0 | $30M | +52% | 3.1M | 9.73 |
|
| Abeona Therapeutics Com New (ABEO) | 1.0 | $29M | +7% | 5.5M | 5.27 |
|
| Ridenow Group Com Cl B (RDNW) | 0.9 | $28M | 5.0M | 5.52 |
|
|
| Rapt Therapeutics Com New (RAPT) | 0.8 | $26M | +20% | 754k | 33.87 |
|
| Fractyl Health (GUTS) | 0.8 | $24M | -10% | 11M | 2.20 |
|
| Avalo Therapeutics Com New (AVTX) | 0.7 | $22M | 1.2M | 18.16 |
|
|
| Abivax Sa Sponsored Ads (ABVX) | 0.7 | $21M | -72% | 153k | 134.85 |
|
| Eton Pharmaceuticals (ETON) | 0.7 | $20M | 1.2M | 16.91 |
|
|
| Globus Med Cl A (GMED) | 0.6 | $20M | -25% | 225k | 87.31 |
|
| Adc Therapeutics Sa SHS (ADCT) | 0.6 | $19M | +141% | 5.5M | 3.53 |
|
| Fossil (FOSL) | 0.6 | $19M | +35% | 5.1M | 3.76 |
|
| Live Nation Entertainment Put Option (LYV) | 0.6 | $19M | 130k | 142.50 |
|
|
| Titan Machinery (TITN) | 0.6 | $18M | +11% | 1.2M | 15.04 |
|
| Imax Corp Cad (IMAX) | 0.6 | $18M | -52% | 477k | 36.96 |
|
| Rmr Group Cl A (RMR) | 0.6 | $17M | 1.1M | 14.90 |
|
|
| Uniqure Nv SHS (QURE) | 0.6 | $17M | -30% | 699k | 23.93 |
|
| Jack in the Box (JACK) | 0.5 | $16M | +44% | 866k | 18.95 |
|
| MiMedx (MDXG) | 0.5 | $16M | +64% | 2.4M | 6.77 |
|
| America's Car-Mart (CRMT) | 0.5 | $16M | 645k | 25.26 |
|
|
| Zevra Therapeutics Com New (ZVRA) | 0.5 | $16M | -10% | 1.8M | 8.96 |
|
| Rh (RH) | 0.5 | $16M | +75% | 88k | 179.15 |
|
| Align Technology Call Option (ALGN) | 0.5 | $16M | 100k | 156.15 |
|
|
| Dianthus Therapeutics (DNTH) | 0.5 | $16M | 375k | 41.21 |
|
|
| Chime Finl Com Shs Cl A Call Option (CHYM) | 0.5 | $15M | NEW | 600k | 25.17 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 0.5 | $15M | 675k | 22.26 |
|
|
| Trisalus Life Sciences (TLSI) | 0.5 | $15M | 2.1M | 6.98 |
|
|
| Astria Therapeutics | 0.5 | $14M | 1.1M | 13.09 |
|
|
| Benitec Biopharma Com New (BNTC) | 0.5 | $14M | +23% | 1.0M | 13.47 |
|
| Apyx Medical Corporation (APYX) | 0.5 | $14M | +19% | 4.0M | 3.50 |
|
| Upstream Bio (UPB) | 0.4 | $13M | -16% | 495k | 27.15 |
|
| Jefferson Capital (JCAP) | 0.4 | $13M | 600k | 22.34 |
|
|
| 1 800 Flowers Cl A (FLWS) | 0.4 | $13M | 3.4M | 3.93 |
|
|
| Service Pptys Tr Com Sh Ben Int (SVC) | 0.4 | $13M | 7.1M | 1.84 |
|
|
| Anteris Technologies Global (AVR) | 0.4 | $13M | +31% | 2.5M | 4.99 |
|
| Keros Therapeutics (KROS) | 0.4 | $12M | -58% | 610k | 20.36 |
|
| Geron Corporation (GERN) | 0.4 | $12M | 9.0M | 1.32 |
|
|
| Aura Biosciences (AURA) | 0.4 | $12M | 2.1M | 5.45 |
|
|
| USANA Health Sciences (USNA) | 0.4 | $12M | NEW | 585k | 19.63 |
|
| Rayonier Advanced Matls (RYAM) | 0.4 | $11M | +252% | 1.8M | 5.89 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $11M | NEW | 1.4M | 7.80 |
|
| Disc Medicine (IRON) | 0.3 | $11M | -53% | 133k | 79.41 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.3 | $10M | -10% | 836k | 12.08 |
|
| Pepgen (PEPG) | 0.3 | $10M | NEW | 1.5M | 6.51 |
|
| Golden Entmt (GDEN) | 0.3 | $10M | NEW | 368k | 27.19 |
|
| Lexeo Therapeutics (LXEO) | 0.3 | $9.9M | NEW | 1.0M | 9.93 |
|
| X4 Pharmaceuticals Com New (XFOR) | 0.3 | $9.8M | +9% | 2.4M | 4.00 |
|
| Ocuphire Pharma (IRD) | 0.3 | $9.6M | +42% | 4.8M | 2.01 |
|
| Silence Therapeutics Ads (SLN) | 0.3 | $9.4M | +47% | 1.5M | 6.08 |
|
| Meta Financial (CASH) | 0.3 | $9.3M | +1477% | 132k | 71.00 |
|
| Industrial Logistics Pptys T Com Shs Ben Int (ILPT) | 0.3 | $9.3M | 1.7M | 5.54 |
|
|
| Solid Biosciences Com New (SLDB) | 0.3 | $9.0M | -5% | 1.6M | 5.64 |
|
| Lawson Products (DSGR) | 0.3 | $9.0M | +43% | 330k | 27.39 |
|
| Cortexyme (QNCX) | 0.3 | $9.0M | -13% | 2.7M | 3.35 |
|
| Cogent Biosciences (COGT) | 0.3 | $8.9M | -83% | 250k | 35.52 |
|
| eHealth (EHTH) | 0.3 | $8.1M | 1.8M | 4.60 |
|
|
| Inhibikase Therapeutics Com New (IKT) | 0.3 | $8.1M | +79% | 3.9M | 2.05 |
|
| Integer Hldgs (ITGR) | 0.3 | $8.0M | NEW | 102k | 78.43 |
|
| Columbus McKinnon (CMCO) | 0.3 | $7.8M | 450k | 17.25 |
|
|
| Reservoir Media (RSVR) | 0.2 | $7.1M | 941k | 7.57 |
|
|
| Hain Celestial (HAIN) | 0.2 | $7.0M | +117% | 6.5M | 1.07 |
|
| Viemed Healthcare (VMD) | 0.2 | $6.9M | 932k | 7.43 |
|
|
| Tela Bio (TELA) | 0.2 | $6.9M | 5.9M | 1.18 |
|
|
| Codexis (CDXS) | 0.2 | $6.5M | 4.0M | 1.63 |
|
|
| Dariohealth Corp (DRIO) | 0.2 | $6.4M | 563k | 11.38 |
|
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $6.4M | -37% | 255k | 25.01 |
|
| Inspiremd (NSPR) | 0.2 | $6.0M | 3.4M | 1.78 |
|
|
| Unicycive Therapeutics Com New (UNCY) | 0.2 | $5.4M | 939k | 5.77 |
|
|
| Assertio Holdings Com New (ASRT) | 0.2 | $5.3M | NEW | 587k | 9.07 |
|
| Surrozen Com New (SRZN) | 0.2 | $5.2M | 230k | 22.60 |
|
|
| Korro Bio (KRRO) | 0.2 | $4.8M | NEW | 600k | 8.01 |
|
| Nektar Therapeutics Com New (NKTR) | 0.2 | $4.8M | -73% | 113k | 42.28 |
|
| Neuropace (NPCE) | 0.2 | $4.6M | 295k | 15.44 |
|
|
| Cg Oncology (CGON) | 0.2 | $4.5M | 109k | 41.52 |
|
|
| Alta Equipment Group Common Stock (ALTG) | 0.1 | $4.3M | 935k | 4.60 |
|
|
| Destination Xl (DXLG) | 0.1 | $4.1M | 4.5M | 0.92 |
|
|
| Mineralys Therapeutics (MLYS) | 0.1 | $4.1M | -28% | 113k | 36.29 |
|
| Acasti Pharma (GRCE) | 0.1 | $4.1M | 1.2M | 3.46 |
|
|
| Talphera Com New (TLPH) | 0.1 | $4.0M | 3.5M | 1.14 |
|
|
| Mara Holdings Note 3/0 (Principal) | 0.1 | $3.9M | NEW | 5.0M | 0.79 |
|
| One Group Hospitality In (STKS) | 0.1 | $3.7M | 2.1M | 1.75 |
|
|
| Dhi (DHX) | 0.1 | $3.7M | 2.4M | 1.55 |
|
|
| Verastem Com New (VSTM) | 0.1 | $3.6M | -64% | 462k | 7.72 |
|
| Arvinas Ord (ARVN) | 0.1 | $3.6M | NEW | 300k | 11.86 |
|
| Orthopediatrics Corp. (KIDS) | 0.1 | $3.5M | +303% | 199k | 17.76 |
|
| Gaia Cl A (GAIA) | 0.1 | $3.3M | 915k | 3.63 |
|
|
| Achieve Life Sciences (ACHV) | 0.1 | $3.2M | 649k | 4.97 |
|
|
| Akebia Therapeutics (AKBA) | 0.1 | $3.2M | 2.0M | 1.61 |
|
|
| Scully Royalty Com Shs (SRL) | 0.1 | $3.1M | 368k | 8.55 |
|
|
| NN (NNBR) | 0.1 | $3.1M | 2.4M | 1.28 |
|
|
| Anebulo Pharmaceuticals (ANEB) | 0.1 | $3.1M | 3.0M | 1.01 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $3.1M | -74% | 443k | 6.90 |
|
| BRC Com Cl A (BRCC) | 0.1 | $2.9M | 2.6M | 1.11 |
|
|
| Noodles & Co Com Cl A (NDLS) | 0.1 | $2.9M | -8% | 4.1M | 0.71 |
|
| Aytu Biopharma (AYTU) | 0.1 | $2.8M | 1.1M | 2.60 |
|
|
| Payoneer Global (PAYO) | 0.1 | $2.7M | 484k | 5.62 |
|
|
| Xencor (XNCR) | 0.1 | $2.5M | -85% | 165k | 15.31 |
|
| Immunic (IMUX) | 0.1 | $2.3M | NEW | 4.4M | 0.53 |
|
| Elutia Cl A Com (ELUT) | 0.1 | $2.2M | 3.2M | 0.69 |
|
|
| Kosmos Energy (KOS) | 0.1 | $2.1M | +36% | 2.3M | 0.91 |
|
| Reading Intl Cl A (RDI) | 0.1 | $2.0M | 1.9M | 1.05 |
|
|
| Kezar Life Sciences Com New (KZR) | 0.1 | $1.7M | NEW | 277k | 6.29 |
|
| Vaxcyte Call Option (PCVX) | 0.1 | $1.6M | NEW | 35k | 46.14 |
|
| Perfect Corp Cl A Ord Shs (PERF) | 0.0 | $1.1M | 584k | 1.81 |
|
|
| Altisource Portfolio Solutio *w Exp 04/30/203 (ASPSW) | 0.0 | $1.0M | 2.5M | 0.41 |
|
|
| Senti Biosciences Com New (SNTI) | 0.0 | $924k | 888k | 1.04 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.0 | $909k | NEW | 58k | 15.68 |
|
| Edesa Biotech Com New (EDSA) | 0.0 | $888k | 625k | 1.42 |
|
|
| Acme United Corporation (ACU) | 0.0 | $823k | 20k | 40.31 |
|
|
| Altisource Portfolio Solutio *w Exp 04/02/202 (ASPSZ) | 0.0 | $818k | 2.5M | 0.33 |
|
|
| Vyne Therapeutics (VYNE) | 0.0 | $580k | NEW | 1.0M | 0.58 |
|
| Spar (SGRP) | 0.0 | $532k | 661k | 0.81 |
|
|
| Strata Skin Sciences (SSKN) | 0.0 | $509k | 404k | 1.26 |
|
|
| Biomx Com New (PHGE) | 0.0 | $215k | NEW | 115k | 1.87 |
|
| Kiora Pharmaceuticals (KPRX) | 0.0 | $209k | -32% | 106k | 1.97 |
|
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $207k | NEW | 626k | 0.33 |
|
| Aprea Therapeutics Com New (APRE) | 0.0 | $176k | 206k | 0.85 |
|
|
| Lucid Diagnostics (LUCD) | 0.0 | $103k | 95k | 1.09 |
|
|
| Context Therapeutics (CNTX) | 0.0 | $56k | -97% | 38k | 1.47 |
|
| Guardforce Ai *w Exp 10/01/202 (GFAIW) | 0.0 | $23k | 154k | 0.15 |
|
|
| Perfect Corp *w Exp 99/99/999 (PERF.WS) | 0.0 | $323.107500 | 16k | 0.02 |
|
Past Filings by Nantahala Capital Management
SEC 13F filings are viewable for Nantahala Capital Management going back to 2011
- Nantahala Capital Management 2025 Q4 filed Feb. 13, 2026
- Nantahala Capital Management 2025 Q3 filed Nov. 14, 2025
- Nantahala Capital Management 2025 Q2 filed Aug. 14, 2025
- Nantahala Capital Management 2025 Q1 filed May 15, 2025
- Nantahala Capital Management 2024 Q4 filed Feb. 14, 2025
- Nantahala Capital Management 2024 Q3 filed Nov. 14, 2024
- Nantahala Capital Management 2024 Q2 amended filed Aug. 20, 2024
- Nantahala Capital Management 2024 Q2 filed Aug. 14, 2024
- Nantahala Capital Management 2024 Q1 filed May 15, 2024
- Nantahala Capital Management 2023 Q4 amended filed Feb. 15, 2024
- Nantahala Capital Management 2023 Q4 filed Feb. 14, 2024
- Nantahala Capital Management 2023 Q3 filed Nov. 14, 2023
- Nantahala Capital Management 2023 Q2 filed Aug. 14, 2023
- Nantahala Capital Management 2023 Q1 filed May 15, 2023
- Nantahala Capital Management 2022 Q4 filed Feb. 14, 2023
- Nantahala Capital Management 2022 Q3 filed Nov. 10, 2022